comparemela.com

Latest Breaking News On - Wilmer eye institute - Page 3 : comparemela.com

Peter A Campochiaro, MD: Phase 1/2a Data on RGX-314 Gene Therapy for Wet AMD

Peter A. Campochiaro, MD, discusses the safety and tolerability of RGX-314 gene therapy in treating wet AMD and how these results inform pivotal clinical trials.

Petera campochiaroJohns hopkins university school of medicineWilmer eye instituteJohns hopkins university school

CGM Use Linked to Lower Diabetic Retinopathy Risk in Type 1 Diabetes

CGM use was associated with lower risks for diabetic retinopathy and proliferative diabetic retinopathy among adults with type 1 diabetes.

Wilmer eye instituteDiabetes centerJohns hopkins endocrineArea deprivation index

Vision Impairment Associated with Symptoms of Depression, Anxiety

Worse examination-based and self-reported vision impairment was associated with depressive and anxiety symptoms among adults aged ≥65 years.

Pradeepy ramuluJohns hopkins university school of medicineWilmer eye instituteNational health interviewNational healthJohns hopkins medicineAging trends studyJohns hopkins university schoolPsychosocial functionReported vision impairmentFood insecurityNational health interview survey

Opthea Appoints Arshad M Khanani, MD, MA, FASRS, as Chief Medical Advisor

Global retina expert joins to support sozinibercept development and launch preparationMELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) Opthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor. An internationally recognized retina specialist and clinical scientist, Dr. Khanani i

University of nevadaUnited statesFrederic guerardArshadm khananiRudi michelsonMacula societyOpthea limitedReno school of medicineMonsoon communicationsAmerican society of retina specialistsFellowship at sierra eye associatesExchange commissionWilmer eye institute at johns hopkins universityClinical researchAstellas companySierra eye associates

Opthea Appoints Arshad M Khanani, MD, MA, FASRS, as Chief Medical Advisor - Opthea (NASDAQ:OPT)

MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) Opthea Limited ((ASX:OPT, NASDAQ:OPT, "Opthea")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive

United statesUniversity of nevadaArshadm khananiFrederic guerardRudi michelsonClinical researchOpthea limitedRetina societyExchange commissionMonsoon communicationsMacula societyAstellas companyReno school of medicineSierra eye associatesWilmer eye institute at johns hopkins universityAmerican society of retina specialists

vimarsana © 2020. All Rights Reserved.